Medication info
Eden Memantine Tablet 10 mg (Memantine Hydrochloride)

Eden Memantine Tablet 10 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
Domestic - 30 tablets/bottle - 30 tablets/bottle [30 tablets/bottle], Domestic - 100 tablets/bottle - 100 tablets/bottle [100 tablets/bottle]
Approval status
Active

MFDS item code 201903153 · Approved 2019.05.15 · Insurance code 628902430

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver can periodically confirm that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed periodically. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, the dose should be increased by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg once daily for 7 days. Week 2 (Days 8–14) Administer 10mg once daily for 7 days. Week 3 (Days 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose in patients 65 years of age and older is 20mg once daily. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dosage adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, administration of this medicine is not recommended.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of patients with moderate to severe Alzheimer's disease.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver can periodically confirm that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed periodically. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, the dose should be increased by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg once daily for 7 days. Week 2 (Days 8–14) Administer 10mg once daily for 7 days. Week 3 (Days 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose in patients 65 years of age and older is 20mg once daily. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dosage adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, administration of this medicine is not recommended.

Precautions

This medication should not be used in patients who are allergic to any of its ingredients. It is also safe not to administer it to patients with severely impaired liver function or significantly reduced kidney function. Care should be taken when using in patients with a history of seizures or convulsions, and those at high risk of seizures should also be cautious. Co-administration with other medications that have similar effects may increase central nervous system side effects, so it should be avoided. Patients with changes in urine acidity or those who have had recent heart disease should also use it cautiously. Side effects such as dizziness, headaches, constipation, drowsiness, and hypertension may occur during treatment, and any unusual symptoms should be reported. It can interact with several medications, so if you are taking other medications, be sure to inform a physician or pharmacist. Women who are pregnant or may become pregnant should use it only after consulting a physician, and breastfeeding women should preferably discontinue breastfeeding. Safety and efficacy have not been established in children or adolescents under 18 years of age, so it should not be used in this population. In cases of overdose, symptoms such as confusion, drowsiness, hallucinations, and seizures may occur, so contact a medical facility immediately, and special antidotes are not available, so symptomatic treatment is necessary. This medication can affect the patient's reaction speed, so precautions should be taken when driving or operating machinery. Keep out of reach of children and do not transfer to other containers for safety.

Side effects

  • dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychotic reaction
Show 25 more
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • venous thrombosis
  • thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • agitation
  • aggression
  • confusion
  • unconsciousness
  • double vision
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a sealed container. Additionally, it is best to keep the medication at room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

Domestic - 30 tablets/bottle - 30 tablets/bottle [30 tablets/bottle], Domestic - 100 tablets/bottle - 100 tablets/bottle [100 tablets/bottle]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.